Be part of the knowledge.™

Prova Education

Prova Education designs educational programs that address a broad spectrum of gaps in awareness, attitudes, skills, and competencies related to guideline-based care and evolving disease management options. Its mission is to serve as an innovative and relevant resource for clinical content that promotes change in practice and patient outcomes.

742

LikeLikedUnlike

106-120 of 127

In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience
CME/CE
In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience
- Darren Brenner, MD
  Peer
- Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
  Peer
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CE
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
- Danielle Becker, MD, MS, FAES
  Peer
- Ahmed Abdelmoity, MD
  Peer
- Deborah Holder, MD
  Peer
- John Stern, MD
  Peer
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
CME/CE
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
- George Thompson III, MD, FIDSA
  Peer
Invasive Fungal Infections: More Common Than You Think
CME/CE
Invasive Fungal Infections: More Common Than You Think
- Peter G. Pappas, MD, FACP
  Peer
- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
CME/CE
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
- William J. Gradishar, MD
  Peer
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
CME/CE
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
- Mamta Parikh, MD, MS
  Peer
- Daniel P. Petrylak, MD
  Peer
advertisement
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
CME/CE
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
- William J. Gradishar, MD
  Peer
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
CME/CE
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
- Robert L. Coleman, MD, FACOG, FACS
  Peer
- Susana Campos, MD, MPH
  Peer
- Domenica Lorusso, MD, PhD
  Peer
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
CME/CE
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
- Benjamin Levy, MD
  Peer
- Rebecca Heist, MD, MPH
  Peer
- Peter Bela Illei, MD
  Peer
MinuteCE®
A Deep Dive into the Management of AEs Associated with ADCs
- Jaffer Ajani, MD
  Peer
- Justin Gainor, MD
  Peer
- Sara A. Hurvitz, MD, FACP
  Peer
- Gopa Iyer, MD
  Peer
HER2-Directed ADCs in Breast Cancer
CME/CE
HER2-Directed ADCs in Breast Cancer
- Sara A. Hurvitz, MD, FACP
  Peer
TROP2-Directed ADCs in Breast Cancer
MinuteCE®
TROP2-Directed ADCs in Breast Cancer
- Sara A. Hurvitz, MD, FACP
  Peer
advertisement
HER3-Directed ADCs in Breast Cancer
MinuteCE®
HER3-Directed ADCs in Breast Cancer
- Sara A. Hurvitz, MD, FACP
  Peer
HER2-Directed ADCs in Lung Cancer
MinuteCE®
HER2-Directed ADCs in Lung Cancer
- Justin Gainor, MD
  Peer
TROP2-Directed ADCs in Lung Cancer
MinuteCE®
TROP2-Directed ADCs in Lung Cancer
- Justin Gainor, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended